Factory 99% Hydroxyethyl Starch Powder CAS 9005-27-0 Hydroxyethyl Starch

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A528
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Hydroxyethyl Starch
• CAS: 9005-27-0
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 10g
• Function: Improve Circulation
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

Product Name	Hydroxyethyl Starch
Appearance	White Powder
CAS NO.	9005-27-0
Molecular Formula	C22H44O17
Storage	Keep in a cool, dry, dark location

 

Hydroxyethyl Starch (HES) is a colloidal solution used in medicine to increase blood volume and improve circulation, particularly in situations where fluid loss has occurred, such as during surgery, trauma, or severe illness.

 

1. Surgical Procedures: HES is commonly used during surgical interventions to maintain adequate blood volume and perfusion, preventing hypotension and tissue hypoxia.
2. Critical Care: In intensive care units, HES can be administered to critically ill patients experiencing fluid loss, helping to stabilize hemodynamic parameters and support organ function.
3. Trauma and Burn Cases: For patients with burns or traumatic injuries, HES aids in the restoration of fluid balance and prevents shock, supporting the body's recovery process.

1. Plasma Volume Expansion: By increasing the oncotic pressure of the blood, HES expands the plasma volume, which helps maintain blood pressure and ensures adequate tissue perfusion.
2. Improved Microcirculation: HES enhances microcirculatory flow, facilitating the delivery of oxygen and nutrients to tissues and aiding in the removal of waste products.
3. Reduced Need for Blood Transfusions: By effectively expanding blood volume, HES can reduce the need for blood transfusions in some patients, minimizing the risks associated with transfusion-related complications.